Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Circassia reports phase II results with ragweed allergy T-cell vaccine

Feb. 15, 2010

Ablynx selected anti-CXCR4 Nanobody ALX-0651 for preclinical development

Feb. 15, 2010

Ligon Discovery and Lycera collaborate to develop drugs for immune disorders

Feb. 12, 2010

Inovio Biomedica reports on phase I trial of its cervical cancer vaccine VGX-3100

Feb. 9, 2010

MF59 adjuvant induces antibody repertoire expansion to H5N1 vaccine

Feb. 9, 2010

Arena discloses S1P1 receptor agonists for autoimmune/inflammatory conditions

Feb. 1, 2010

NCI initiates study for ImmuneRegen's vaccine adjuvant candidate

Jan. 29, 2010

FDA approves Bayer's phase I study with personalized vaccine from tobacco plants

Jan. 29, 2010

Juvaris BioTherapeutics receives financing for further development of JVRS-100 adjuvant

Jan. 28, 2010

Lecithin-based nanoparticle adjuvant induces antibody immune responses

Jan. 20, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...